Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 25 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 9.97 | 265 | 2.64 k | 19,468 |
14 Jun 24 | ARDX Ardelyx | Stock Option Common Stock | Grant | Acquire A | No | No | 6.35 | 40,243 | 255.54 k | 40,243 |
13 Jun 24 | VCYT Veracyte | Common Stock | Grant | Acquire A | No | No | 0 | 11,473 | 0.00 | 34,578 |
12 Jun 24 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 7,737 | 0.00 | 19,733 |
12 Jun 24 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.85 | 11,515 | 297.66 k | 11,515 |
10 Jun 24 | VCYT Veracyte | Common Stock | Sell | Dispose S | No | Yes | 20.3188 | 3,870 | 78.63 k | 23,105 |